Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Byetta (exenatide) – First-in-Class Incretin Mimetic for Type 2 Diabetes

Results from clinical trials reported to date suggest Exenatide is well tolerated.

Go Top